Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1995
11/22/1995EP0682704A1 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
11/22/1995EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
11/22/1995EP0682529A1 Antibody for the treatment of insulin dependent diabetes
11/22/1995EP0682528A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
11/22/1995EP0682527A1 Carbohydrate-based vaccine and diagnostic reagent for trichinosis
11/22/1995EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna
11/22/1995CN1112356A Novel attenuated pseudomonas aeruginosa strains
11/22/1995CN1112022A High immune serum for prevention of aerohydrophilic monadosis and its preparation method
11/22/1995CN1112021A Aluminium hydroxide vaccine for prevention of aerohydrophilic monadosis and its preparation method
11/21/1995US5468777 Method and agents for preventing and reversing the staining of teeth
11/21/1995US5468494 Polypeptides as anticarcinogenic agents
11/21/1995US5468486 Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis
11/21/1995US5468484 Method of prevention of pseudomonas infection
11/21/1995US5468481 Glycoside antigen peptides for autoimmune diseases
11/21/1995US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD
11/21/1995CA2149703A1 Mucosal administration of pneumococcal antigens
11/21/1995CA2149345A1 Epitopic regions of pneumococcal surface protein a
11/21/1995CA1337596C Varicella-zoster virus as a live recombinant vaccine
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof
11/16/1995WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
11/16/1995WO1995030437A1 Improved modified live brsv vaccine
11/16/1995WO1995030436A1 An adjuvant
11/16/1995WO1995030435A2 Compositions and treatment for multiple sclerosis
11/16/1995WO1995030428A1 Human dnase
11/16/1995WO1995030331A1 Compositions and methods of treating tumors
11/16/1995WO1995019371A3 Expression of surface layer proteins
11/16/1995DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines
11/16/1995CA2189990A1 Compositions and treatment for multiple sclerosis
11/16/1995CA2189432A1 An adjuvant
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682108A1 Virus strain against pig pseudorabies and vaccines containing the said virus
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use
11/15/1995EP0681484A1 Immunoreactive reagents employing heterodimers
11/15/1995EP0681483A1 Compositions and methods for delivery of genetic material
11/15/1995EP0681480A1 Recognin vaccines
11/15/1995EP0681479A1 Immunotherapeutic composition
11/15/1995EP0681478A1 Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
11/15/1995EP0681470A1 Recombinant living subunit vaccine composition and process for its preparation.
11/15/1995EP0527977B1 Nematode vaccine
11/15/1995EP0480949B1 Production of virus and purification of viral envelope proteins for vaccine use
11/15/1995EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment
11/15/1995EP0444186B1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
11/15/1995EP0431146B1 Radionuclide metal chelates for the radiolabeling of proteins
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/15/1995CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein
11/14/1995US5466672 Anticancer
11/09/1995WO1995030019A1 Feline immunodeficiency virus vaccine
11/09/1995WO1995030018A2 Recombinant poxviruses with foreign polynucleotides in essential regions
11/09/1995WO1995030016A1 Methods for peptide synthesis and purification
11/09/1995WO1995030015A2 Isolated epstein-barr virus bzlf2 proteins that bind mhc class ii beta chains
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030006A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof
11/09/1995WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination
11/09/1995WO1995029991A1 A novel vzv gene, mutant vzv and immunogenic compositions
11/09/1995WO1995029985A1 Method to identify immunocompromised patients at high risk for cryptococcosis
11/09/1995WO1995029934A1 Method of separating protective components of bordetella pertussis
11/09/1995WO1995029925A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
11/09/1995WO1995029707A1 Composition for delivery of toxic radioisotopes to the cell nucleus and use
11/09/1995WO1995029701A1 Vaccines for oral immunization against infecting agents
11/09/1995WO1995029700A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995WO1995029699A1 Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
11/09/1995WO1995029698A1 Tumor-associated antigen peptides and their use in tumor diagnosis and therapy
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995WO1995029662A2 Vaccine against gram-negative bacterial infections
11/09/1995WO1995024896A3 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
11/09/1995DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2189470A1 Method to identify immunocompromised patients at high risk for cryptococcosis
11/09/1995CA2189469A1 Vaccines for oral immunization against infecting agents
11/09/1995CA2189045A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995CA2188565A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
11/09/1995CA2188424A1 Method of separating protective components of bordetella pertussis
11/09/1995CA2165413A1 Methods for peptide synthesis and purification
11/08/1995EP0681026A1 Recombinant mycobacterial vaccine
11/08/1995EP0680974A1 Novel muramyldipeptide derivatives
11/08/1995EP0680765A1 Vaccine for nontypable haemophilus influenzae strain
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680512A1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
11/08/1995EP0680338A1 Ganglioside-klh conjugate vaccines with qs-21
11/08/1995EP0680337A1 Methods and compositions for the direct concentrated delivery of passive immunity
11/08/1995EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
11/08/1995EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0563254B1 Use of il-4 to enhance immune response to immunogens in vaccines
11/08/1995EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
11/08/1995EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/08/1995EP0306496B1 Method for reducing the toxicity of lps and method for detoxifying an lps-containing therapeutic liquid
11/08/1995CN1111284A Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene
11/08/1995CN1111158A Products containing G-CSF and TNF binding protein
11/08/1995CN1111157A Method and formulation for orally adminstering bioactive agents to and through the peyer's patch
1 ... 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 ... 1823